CJC-1295 Research Overview
CJC-1295 is a growth hormone releasing hormone (GHRH) analogue peptide engineered with specific amino acid substitutions at positions 2, 8, 15, and 27 of the native GHRH(1-29) sequence. This synthetic modification enhances molecular stability while preserving high-affinity binding to GHRH receptors in preclinical models. Research teams at Stroid UK Shop investigate this compound’s distinctive pharmacokinetic properties and receptor interaction profiles. The peptide demonstrates extended half-life characteristics compared to natural GHRH, making it valuable for sustained growth hormone pathway research protocols. Studies examine its mechanism of action through selective receptor activation that stimulates anterior pituitary growth hormone secretion in experimental systems.
Laboratory Applications
Research applications focus on growth hormone axis modulation studies where CJC-1295’s unique molecular structure provides investigators with precise experimental control. Cell culture experiments examine receptor binding kinetics and downstream signaling pathway activation. Animal model studies investigate pulsatile growth hormone release patterns and circadian rhythm influences on peptide effectiveness. Comparative research protocols evaluate CJC-1295 against other peptide compounds to establish selectivity profiles and binding affinity differences. Advanced studies explore potential synergistic effects when combined with growth hormone secretagogue peptides available through specialized CJC-1295 research collections. Investigators also examine metabolic pathway interactions and cellular energy utilization patterns influenced by growth hormone pathway stimulation. Some research teams compare this peptide’s properties with selective androgen receptor modulators to understand different anabolic signaling mechanisms.
Technical Specifications
| Parameter | Value |
|---|---|
| CAS Number | 863288-34-0 |
| Molecular Weight | 3367.97 g/mol |
| Purity | ≥98% |
| Storage Temperature | -20°C (lyophilized) |
| Reconstitution | Bacteriostatic water recommended |
| Stability | 2-8°C after reconstitution, use within 30 days |
Research Compliance
CJC-1295 is supplied exclusively for in-vitro research applications and laboratory studies. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must maintain proper laboratory protocols and documentation for all experimental procedures. Storage conditions must be strictly controlled to preserve peptide integrity throughout research studies.
